Consumption of alcohol in the presence of hepatitis C virus is an additive risk for liver damage

Preventive Medicine

Volumn 27, Issue 3, 1998, Pages 461-469

  Ohta, Setsuko ^a   Watanabe, Yohko ^b   Nakajima, Tamie ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kiso Pub Hlth Ctr of Nagano Pref   (Japan)

Author keywords

Alanine aminotransferase; Alcohol drinking; Antibodies to hepatitis C virus; Aspartate aminotransferase; Hepatitis C virus; Latent infection; Liver injury; glutamyl transpeptidase

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; INCIDENCE; JAPAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031880792     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1998.0298     Document Type: Article

References (30)

1. Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;59-62.
2. Kuo G, Choo Q L, Alter H J, Gitnick G L, Redeker A G, Purcell R H. An assay for circulating antibodies to a major etiologic virus of human non-A,non-B hepatitis. Science. 244:1989;362-364.
3. Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol. 12:1991;70-74.
4. Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol. 12:1991;367-371.
5. Poynard T, Aubet A, Lazizi Y, Bedossa P, Hamelin B, Terris B. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology. 13:1991;896-901.
6. Esteban R. Epidemiology of hepatitis C virus infection. J Hepatol. 17:1993;67-71.
7. Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology. 17:1993;9-13.
8. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcohol iccirrhosis. Hepatology. 18:1993;47-53.
9. Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohta M. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol. 88:1993;39-43.
10. Chang C C, Yu M W, Lu C F, Yang C S, Chen C J. A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9775 men in Taiwan. J Med Virol. 43:1994;276-280.
11. Tong M J, El-Farra N, Reikes A R, Co R L. Clinical outcomes after transfusion associated hepatitis C. N Engl J Med. 332:1995;1463-1466.
12. Age-adjusted death rates by prefecture: special report on vital statistics 1990. 1992.
13. Shiomi S, Kuroki T, Minamitani S, Ueda T, Nishiguchi S, Nakajima S. Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol. 7:1992;274-276.
14. Corrao G, Carle F, Lepore A R, Zepponi E, Galatola G. Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: a case-control study. Eur J Epidemiol. 8:1992;634-639.
15. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology. 106:1994;1596-1602.
16. Watanabe Y, Machida K, Sato A, Ota S, Kiyosawa K. Survey for hepatitis in an isolated endemic area. Jpn J Public Health. 43:1996;989-996.
17. Sakai Y, Takayama T, Fukuda Y, Kiyosawa K. Etiologic and clinical studies of hepatitis C in an epidemic area in Japan. Jpn J Clin Med. 53:1995;377-382.
18. Hung K Y, Lee K C, Yen C J, Wu K D, Tsai T J, Chen W Y. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant. 12:1997;180-183.
19. Okuda K, Hayashi H, Yokozeki K, Kondo T, Kashima T, Irie Y. Interferon treatment for chronic hepatitis C in haemodialysis patient. J Gastroenterol Hepatol. 10:1995;616-620.
20. Katakami Y, Ohishi H, Komatsu H, Kirizuka K. Alcohol intake increases hepatitis C virus-induced hepatocellular injury. Intern Med. 34:1995;1153-1157.
21. Ohkoshi S, Tawaraya H, Kuwana K, Harada T, Watanabe M, Higuchi S. A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier. Dig Dis Sci. 40:1995;465-471.
22. Cicognani C, Malavolti M, Morselli-Labate A M, Zamboni L, Sama C, Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med. 157:1997;792-796.
23. Monna T, Okuda K. Thymol turbidity test (TTT), zinc sulfate turbidity test (ZTT). Jpn J Clin Med. 53:1995;163-170.
24. Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology. 20:1994;1115-1120.
25. Bizzaro N, Tremolada F, Casarin C, Bonetti P, Oventa F, Dioati G. Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity. Ital J Gastroenterol. 24:1992;237-241.
26. Ueno H, Esaki H, Momose Y, Ishii T, Watanabe D, Shigematsu T. Hepatitis B surface antigen, hepatitis C virus antibody, body mass index, and alcohol drinking among workers with elevated serum alanine aminotransferase. Prev Med. 23:1994;442-446.
27. Bernadt M W, Mumford J, Taylor C, Smith B, Murray R M. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet. 1:1982;325-328.
28. Ryback R S, Eckardt M J, Felster B, Rawlings R R. Biochemical and hematologic correlates of alcoholism and liver disease. J Am Med Assoc. 248:1982;2261-2265.
29. Nakajima T, Ohta S, Fujita H, Murayama N, Sato A. Carbohydrate-related regulation of the ethanol-induced increase in serum γ-glutamyl transpeptidase activity in adult men. Am J Clin Nutr. 60:1994;87-92.
30. Tanaka J, Moriya T, Sasaki F, Yoshizawa H. Prevalence of anti C100-3 and HBsAg in blood donors: comparative study of total collected blood units, total collection adjusted to exclude repeat blood donations, and in first time blood donors. Jpn J Public Health. 40:1993;540-546.